Intel advances on Apple chip deal, shares touch a fresh record on Nasdaq
22.06.2026 - 20:30:22 | ad-hoc-news.de
By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-22, 20:28.
Intel (US4581401001) is back in the spotlight after reports that Apple plans to use the U.S. chipmaker as a foundry partner for domestically produced processors. The Nasdaq-listed shares hit a fresh record high around 141 dollars in Monday trading, supported by optimism around the company’s AI and manufacturing roadmap according to market data and analyst commentary.
Apple partnership drives new record
According to several market reports, Intel shares have been extending recent gains after former U.S. President Donald Trump said Apple had agreed to work with the company to design and manufacture chips in the United States, a move that investors read as a strategic win for Intel’s foundry push. StockAnalysis summary on Intel’s all-time high The partnership narrative has pushed the stock to a new all-time high near 141.45 dollars on Nasdaq, compared with a 52-week low below 19 dollars earlier in the cycle, highlighting the magnitude of the rerating.
Trading data show that Intel shares on Nasdaq moved in a daily range between roughly 136 and 141 dollars on Monday, with volumes significantly above recent averages as investors repositioned into U.S. semiconductor names. Intel quote and trading data The move keeps the stock firmly in focus within the S&P 500 and NASDAQ-100 semiconductor cohort, where it competes with peers such as Micron and Taiwan Semiconductor on manufacturing capabilities and AI exposure.
Analysts respond to the rally
The speed of the share-price advance is now triggering a more cautious tone from some analysts. Research house Mizuho recently raised its price target on Intel from 128 to 135 dollars but kept a Neutral rating, signaling that valuation is catching up with the improving fundamental story after the latest Apple-related surge. Mizuho target change cited in analyst roundup Aggregate consensus data still show the stock rated Hold on average, with a mean target in the mid-90 dollar range, well below the current trading zone.
Some market commentators describe the rally as increasingly sentiment-driven, pointing to social-media interest and speculative flows, while others emphasize the structural upside from Intel’s 18A process technology and advanced packaging roadmap in the AI cycle. MarketBeat review of Intel’s AI and foundry thesis For long-term investors the key question is whether the Apple-related momentum can be translated into a broader, sustainable foundry customer base.
All news and analysis on the Intel shares
Latest corporate releases, analyst ratings and trading data on Intel are collected in the dedicated topic section.
How Intel makes its money
Intel’s business model is built around designing and manufacturing x86 central processing units for PCs and servers, alongside a growing data center and AI accelerator portfolio. A key representative product line is the Intel Core processor family for consumer and business PCs, which pairs with chipsets and connectivity solutions to form complete platforms for OEMs.
Where the stock trades today
The Intel shares (US4581401001) trade on Nasdaq under the ticker INTC and most recently changed hands at about 140.5 dollars on 2026-06-22, 19:59, reflecting a new all-time high region for the stock in U.S. trading.
Key data on the Intel shares
- Company: Intel Corporation
- ISIN: US4581401001
- WKN: 855681
- Ticker: INTC
- Trading venue: Nasdaq
- Price (as of 2026-06-22, 19:59): 140.55 USD
- Market cap: 707.61 billion USD (as of 2026-06-22)
- Sector / industry: Semiconductors and semiconductor equipment
- Index membership: S&P 500, NASDAQ-100
- Next earnings date: 2026-07-23
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. All data are based on sources considered reliable but cannot be guaranteed. Investors should conduct their own research and consider their individual risk profile.
